Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study

被引:0
|
作者
Gurley, Tami [1 ]
Hernaez, Ruben [2 ,3 ]
Cerda, Vanessa [1 ]
Thomas, Tynaje [1 ]
Narasimman, Manasa [4 ]
Mittal, Sukul [4 ]
Al-Hasan, Mohammed [4 ]
Daher, Darine [4 ]
Singal, Amit G. [4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Donnell Sch Publ Hlth, Dallas, TX USA
[2] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA
[3] Baylor Coll Med, Houston, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
关键词
Liver cancer; Screening; Ultrasound; Outreach; Interventions; HEPATOCELLULAR-CARCINOMA SURVEILLANCE; DECOMPENSATED CIRRHOSIS; ASSOCIATION; OUTCOMES; QUALITY; DISEASE; LIFE;
D O I
10.1016/j.eclinm.2025.103113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with cirrhosis are at high risk for hepatocellular carcinoma (HCC), but few undergo guideline- recommended semi-annual screening. Randomized clinical trials (RCTs) demonstrate that mailed outreach can increase screening versus visit-based screening. We estimated the costs and cost-effectiveness of an outreach strategy versus usual care. Methods We built a 10-year Markov chain Monte Carlo microsimulation model to conduct a cost-effectiveness analysis comparing a mailed outreach program versus usual care for HCC screening in a cohort of 10,000 patients with cirrhosis. Model inputs were based on literature review (2005-current), and costs were based on inflation-adjusted estimates from Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data. We conducted one-way sensitivity analyses for HCC incidence, outreach costs, efficacy of the outreach strategy to increase screening, and efficacy of curative (versus palliative) HCC treatments. Findings Mailed outreach was estimated to cost $32.45 per patient in the first year and $21.90 per patient in subsequent years. The outreach program increased the number of HCC patients detected at an early stage by 48.4% and increased quality-adjusted life years (QALYs) by 300. Cost savings from these increases offset the costs of mailed outreach. Mailed outreach remained cost-effective across a wide range of HCC incidence rates, outreach costs, efficacy of the outreach strategy to increase screening, and the efficacy of curative HCC treatments. Annual out-ofpocket patient costs in the outreach arm were low at $13 per year. Interpretation Mailed outreach to encourage HCC screening in patients with cirrhosis dominates usual care and should be considered for implementation in routine practice. Funding National Cancer Institute and Cancer Prevention Research Institute of Texas. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
    Klebanoff, Matthew J.
    Corey, Kathleen E.
    Samur, Sumeyye
    Choi, Jin G.
    Kaplan, Leem.
    Chhatwal, Jagpreet
    Hur, Chin
    JAMA NETWORK OPEN, 2019, 2 (02) : e190047
  • [32] Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program
    Rim, Sun Hee
    Allaire, Benjamin T.
    Ekwueme, Donatus U.
    Miller, Jacqueline W.
    Subramanian, Sujha
    Hall, Ingrid J.
    Hoerger, Thomas J.
    CANCER CAUSES & CONTROL, 2019, 30 (08) : 819 - 826
  • [33] Cost-effectiveness analysis of hearing screening program for primary school children in southern Iran, Shiraz
    Faramarzi, Mohammad
    Fard, Sara Babakhani
    Bayati, Mohsen
    Jafarlou, Fatemeh
    Parhizgar, Mohammadreza
    Rezaee, Mehdi
    Keshavarz, Khosro
    BMC PEDIATRICS, 2022, 22 (01)
  • [34] A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola
    McGann, Patrick T.
    Grosse, Scott D.
    Santos, Brigida
    de Oliveira, Vysolela
    Bernardino, Luis
    Kassebaum, Nicholas J.
    Ware, Russell E.
    Airewele, Gladstone E.
    JOURNAL OF PEDIATRICS, 2015, 167 (06): : 1314 - 1319
  • [35] Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study
    Villanueva-Uy, Maria Esterlita T.
    Lam, Hilton Y.
    Aldaba, Josephine G.
    Uy, Tristan Marvin Z.
    Valverde, Haidee A.
    Silva, Maria Wilda T.
    Mooney, Jessica
    Clark, Andrew
    Pecenka, Clint
    VACCINE, 2021, 39 (48) : 7091 - 7100
  • [36] A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom
    Wilson, Edward C. F.
    Usher-Smith, Juliet A.
    Emery, Jon
    Corrie, Pippa
    Walter, Fiona M.
    VALUE IN HEALTH, 2018, 21 (06) : 658 - 668
  • [37] Cost-effectiveness of newborn screening for severe combined immunodeficiency
    Van der Ploeg, Catharina P. B.
    Blom, Maartje
    Bredius, Robbert G. M.
    van der Burg, Mirjam
    Schielen, Peter C. J., I
    Verkerk, Paul H.
    Van den Akker-van Marle, M. Elske
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (05) : 721 - 729
  • [38] Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study
    Lee, Yujin
    Mozaffarian, Dariush
    Sy, Stephen
    Huang, Yue
    Liu, Junxiu
    Wilde, Parke E.
    Abrahams-Gessel, Shafika
    Jardim, Thiago de Souza Veiga
    Gaziano, Thomas A.
    Micha, Renata
    PLOS MEDICINE, 2019, 16 (03)
  • [39] Cost-effectiveness of screening for common cancers
    Judith L. Wagner
    Cancer and Metastasis Reviews, 1997, 16 : 281 - 294
  • [40] Cost-effectiveness of screening for common cancers
    Wagner, JL
    CANCER AND METASTASIS REVIEWS, 1997, 16 (3-4) : 281 - 294